November 3, 2025

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.6% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $12.25 billion, this..

Abbott Laboratories (ABT): Investor Outlook with a 16.86% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry with a market capitalization of approximately $214.96 billion, continues to be a significant player in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotechnology Powerhouse with 149% Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out as a formidable player within the biotechnology sector, emphasized by its impressive market capitalization of $60.25 billion. The company’s..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 23.28% Potential Upside with Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a rising star in the healthcare sector, is capturing investor attention with its robust portfolio and diverse segment offerings. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 39.64% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a leading player in the Health Information Services industry, is making waves in the market with its robust cloud-based software solutions..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 10% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical technology industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s..

Moderna, Inc. (MRNA) Stock Analysis: Unveiling a 48% Upside Potential Amidst Industry Challenges

In the fast-evolving biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) stands as a noteworthy player, particularly recognized for its pioneering messenger RNA (mRNA) medicines. Headquartered in Cambridge,..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 3.23% Dividend Yield and Strong Revenue Growth

Novartis AG (NYSE: NVS), a leading player in the global healthcare sector, has long been a staple for investors seeking exposure to the drug manufacturing industry...

Exelixis, Inc. (EXEL) Investor Outlook: A Biotech Powerhouse with a 13.51% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a pioneering force in oncology, continues to capture the attention of investors with its focus on developing innovative treatments for challenging cancers...

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking the 10% Potential Upside with Strong Buy Ratings

For investors eyeing the dynamic intersection of technology and healthcare, Veeva Systems Inc. (NYSE: VEEV) presents a compelling opportunity. With a robust market capitalization of $47.73..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook on Growth Potential and Analyst Consensus

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a stalwart in the healthcare sector, remains a focal point for investors due to its robust position in the specialty..

Ascendis Pharma A/S (ASND) Stock Analysis: A 23.69% Upside Powered by Robust Revenue Growth

For investors seeking exposure to the dynamic biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity. With a market capitalization of $12.21 billion and..

HealthEquity, Inc. (HQY): Analyst Consensus Reveals 28.76% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services industry, has been catching the eye of investors with its robust growth prospects and..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unveiling a 36.67% Upside Potential

Investors eyeing the healthcare sector might find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) an intriguing prospect, particularly given its robust potential for growth. With a market capitalization..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and 14.82% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the drug manufacturers’ industry specializing in both specialty and generic drugs. With a..

DaVita Inc. (DVA) Stock Report: Examining the 21% Potential Upside for Investors

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, specifically within the medical care facilities industry, has garnered attention with its robust potential for..

argenx SE (ARGX) Stock Analysis: Exploring the 12.12% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a dynamic player in the biotechnology sector, continues to capture investor attention with its promising pipeline and significant market presence. As a..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 7.74% Potential Upside for Investors

Doximity, Inc. (NYSE: DOCS) has positioned itself as a formidable player within the healthcare sector, specializing in health information services. With a market capitalization of $12.36..

ResMed Inc. (RMD) Stock Analysis: Unveiling an 18.87% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector specializing in medical instruments and supplies, presents an intriguing prospect for investors seeking growth in the..

Genmab A/S (GMAB) Stock Analysis: Evaluating a Promising 31.47% Upside in Biotechnology

Genmab A/S (NASDAQ: GMAB), a Danish biotechnology powerhouse, has captured the attention of investors with its robust pipeline of antibody-based products targeting cancer and other diseases...

Search

Funds

November 3, 2025

Search

Funds

November 3, 2025

FTSE 100

Funds